evaluation 1
international 1
prognostic 2
score 2
ips 2
simpler 1
advanced 1
hodgkin 1
lymphoma 2
modern 1
era 1
randomized 1
phase 1
ii 1
trial 1
comparing 1
obinutuzumab 1
ga 1
rituximab 1
patients 1
relapsed 1
cd 1
indolent 1
bcell 1
nonhodgkin 1
final 1
analysis 1
gauss 1
study 1
